Komori
Treasury Shares6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Regarding the Status of Share Repurchases

From 13 February to 28 February 2026, the Company acquired 37,300 common shares through market purchases. Cumulative acquisitions against the treasury share acquisition limit approved by the Board of Directors were also the same number of shares and amount.

Worth reading
56In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
37270
Shares
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 12 February 2026 / Acquisition period 13 February 2026 to 31 December 2026

14.9%
Cumulative utilization rate
Limit212,700 株 remaining
Number of Shares250,000 shares (maximum)
—
No Track Record Reported
Limit
Amount¥200 million (maximum)

今回の取得が、そのまま決議後の累計です。

Number of Shares
Limit250,000 shares (maximum)
Cumulative total37,300 株(2026年2月28日時点)
Current37,300 株
Amount
Limit¥200 million (maximum)
Cumulative total27,270,600 円(2026年2月28日時点)
Current27,270,600 円
Percentage of total issued shares4.4% (as a percentage of the total number of issued shares excluding treasury shares)
Average acquisition price for this transaction (calculated)¥731 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。 約定ベース=売買が成立した日を基準に数えた数字です。受け渡しの日ではありません。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction37,300 株
Total current acquisition price27,270,600 円
Acquisition date/acquisition period2026年2月13日から2026年2月28日(約定ベース)
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired37,300 株(2026年2月28日時点)
Cumulative acquisition cost27,270,600 円(2026年2月28日時点)
Resolution date12 February 2026
Maximum number of shares to be acquired250,000 shares (maximum)
Total acquisition price¥200 million (maximum)
Acquisition period under the resolution13 February 2026 to 31 December 2026
Percentage of total issued shares4.4% (as a percentage of the total number of issued shares excluding treasury shares)
Items this document does not state (2)
Whether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

自己株式の取得を行うこと自体は記載されているが、取得理由は記載されていない。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori